Globus Medical Statistics

Total Valuation

Globus Medical has a market cap or net worth of MXN 150.58 billion. The enterprise value is 143.61 billion.

Market Cap	150.58B
Enterprise Value	143.61B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	112.95M
Shares Outstanding	n/a
Shares Change (YoY)	+13.05%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	112.05M

Valuation Ratios

The trailing PE ratio is 39.70 and the forward PE ratio is 17.35.

PE Ratio	39.70
Forward PE	17.35
PS Ratio	2.93
PB Ratio	1.80
P/TBV Ratio	3.91
P/FCF Ratio	14.10
P/OCF Ratio	11.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.21, with an EV/FCF ratio of 13.45.

EV / Earnings	37.86
EV / Sales	3.02
EV / EBITDA	10.21
EV / EBIT	16.66
EV / FCF	13.45

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.02.

Current Ratio	4.45
Quick Ratio	2.60
Debt / Equity	0.02
Debt / EBITDA	0.12
Debt / FCF	0.18
Interest Coverage	198.65

Financial Efficiency

Return on equity (ROE) is 4.63% and return on invested capital (ROIC) is 6.60%.

Return on Equity (ROE)	4.63%
Return on Assets (ROA)	5.90%
Return on Invested Capital (ROIC)	6.60%
Return on Capital Employed (ROCE)	10.54%
Revenue Per Employee	9.68M
Profits Per Employee	715,604
Employee Count	5,300
Asset Turnover	0.52
Inventory Turnover	1.12

Taxes

In the past 12 months, Globus Medical has paid 968.50 million in taxes.

Income Tax	968.50M
Effective Tax Rate	20.34%

Stock Price Statistics

The stock price has increased by +11.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.62%
50-Day Moving Average	1,370.59
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.68
Average Volume (20 Days)	1,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.19

Income Statement

In the last 12 months, Globus Medical had revenue of MXN 51.32 billion and earned 3.79 billion in profits. Earnings per share was 27.30.

Revenue	51.32B
Gross Profit	34.41B
Operating Income	9.32B
Pretax Income	4.76B
Net Income	3.79B
EBITDA	14.73B
EBIT	9.32B
Earnings Per Share (EPS)	27.30

Full Income Statement

Balance Sheet

The company has 9.43 billion in cash and 1.90 billion in debt, giving a net cash position of 7.53 billion.

Cash & Cash Equivalents	9.43B
Total Debt	1.90B
Net Cash	7.53B
Net Cash Per Share	n/a
Equity (Book Value)	83.56B
Book Value Per Share	617.30
Working Capital	27.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.19 billion and capital expenditures -2.51 billion, giving a free cash flow of 10.68 billion.

Operating Cash Flow	13.19B
Capital Expenditures	-2.51B
Free Cash Flow	10.68B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.05%, with operating and profit margins of 18.16% and 7.39%.

Gross Margin	67.05%
Operating Margin	18.16%
Pretax Margin	9.28%
Profit Margin	7.39%
EBITDA Margin	28.70%
EBIT Margin	18.16%
FCF Margin	20.81%

Dividends & Yields

Globus Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.05%
Shareholder Yield	n/a
Earnings Yield	2.52%
FCF Yield	7.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Globus Medical has an Altman Z-Score of 11.03 and a Piotroski F-Score of 5.

Altman Z-Score	11.03
Piotroski F-Score	5